Search Results - keith+pennypacker

2 Results Sort By:
Compositions and Methods for Treating Stroke
Competitive Advantages Reduces neural damage Not dependent on type of stroke Conivaptan is already FDA-approved Greater therapeutic window than current stroke medications Summary USF researchers have developed a method of treating a stroke or suspected stroke by administering a pharmaceutical formulation comprised of conivaptan within 6 hours...
Published: 8/27/2023   |   Inventor(s): David Decker, Keith Pennypacker
Keywords(s):  
Category(s): Technology Classifications > Medical > Pharmaceuticals, Technology Classifications > Medical, Technology Classifications > Medical > Neuroscience
Novel Treatment for Stroke at Delayed Timepoints
Competitive Advantages Enhances behavioral recovery after 30 days Reduces neural damage Extends therapeutic window several-fold Summary The systemic administration of N,N'-di-1 naphthylguanidine HCl (NAGH) and N,N'-di-p-nitrophenylguanidine HCl (NAD) when administered 24 hours after experimental stroke was found to reduce neural damage...
Published: 8/27/2023   |   Inventor(s): Alison Willing, Javier Cuevas, Michelle Cortes-Salva, Keith Pennypacker, Jon Antilla
Keywords(s):  
Category(s): Technology Classifications > Medical > Pharmaceuticals, Technology Classifications > Medical